Cargando…

HIV Latency in Myeloid Cells: Challenges for a Cure

The use of antiretroviral therapy (ART) for Human Immunodeficiency Virus (HIV) treatment has been highly successful in controlling plasma viremia to undetectable levels. However, a complete cure for HIV is hindered by the presence of replication-competent HIV, integrated in the host genome, that can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chitrakar, Alisha, Sanz, Marta, Maggirwar, Sanjay B., Soriano-Sarabia, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230125/ https://www.ncbi.nlm.nih.gov/pubmed/35745465 http://dx.doi.org/10.3390/pathogens11060611

Ejemplares similares

Boosting the Immune System for HIV Cure: A γδ T Cell Perspective
por: Mann, Brendan T., et al.
Publicado: (2020)

Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches
por: Sanz, Marta, et al.
Publicado: (2022)

Defying convention in the time of COVID-19: Insights into the role of γδ T cells
por: Sanz, Marta, et al.
Publicado: (2022)

Platelet-Released Factors: Their Role in Viral Disease and Applications for Extracellular Vesicle (EV) Therapy
por: Ostermeier, Brita, et al.
Publicado: (2022)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)

Comparable Vδ2 Cell Functional Characteristics in Virally Suppressed People Living with HIV and Uninfected Individuals
por: Clohosey, Matthew L., et al.
Publicado: (2020)

Deep latency: A new insight into a functional HIV cure
por: Elsheikh, Maher M., et al.
Publicado: (2019)

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function
por: Garrido, Carolina, et al.
Publicado: (2016)

Latency: the hidden HIV-1 challenge
por: Marcello, Alessandro
Publicado: (2006)

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection
por: Saleh, Suha, et al.
Publicado: (2017)

Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
por: Delannoy, Aurélie, et al.
Publicado: (2019)

Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
por: Ventura, John D.
Publicado: (2020)

HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
por: Denton, Paul W.
Publicado: (2022)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
por: Bricker, Katherine M., et al.
Publicado: (2021)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
por: Clutton, Genevieve Tyndale, et al.
Publicado: (2018)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?
por: Davidson, Donna C, et al.
Publicado: (2013)

Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells
por: Evans, VA, et al.
Publicado: (2010)

Myeloid Dendritic Cells Induce HIV-1 Latency in Non-proliferating CD4(+) T Cells
por: Evans, Vanessa A., et al.
Publicado: (2013)

Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1
por: Sanz, Marta, et al.
Publicado: (2023)

Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1
por: Sanz, Marta, et al.
Publicado: (2023)

Chromatin, gene silencing and HIV latency
por: Mok, Hoi-Ping, et al.
Publicado: (2007)

HIV-1 Latency in Monocytes/Macrophages
por: Kumar, Amit, et al.
Publicado: (2014)

HIV-1 transcription and latency: an update
por: Van Lint, Carine, et al.
Publicado: (2013)

Insights into the HIV Latency and the Role of Cytokines
por: Hokello, Joseph, et al.
Publicado: (2019)

HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure
por: Ash, Michelle K., et al.
Publicado: (2021)

The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary T(CM) Cell Model of Latency
por: Sarabia, Indra, et al.
Publicado: (2021)

Latency function estimation under the mixture cure model when the cure status is available
por: Safari, Wende Clarence, et al.
Publicado: (2023)

Correction: Myeloid Dendritic Cells Induce HIV-1 Latency in Non-proliferating CD4(+) T Cells
Publicado: (2014)

Molecular Understanding of HIV-1 Latency
por: Abbas, W., et al.
Publicado: (2012)

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
por: Coleman, Christopher M, et al.
Publicado: (2009)

Chromatin Regulation and the Histone Code in HIV Latency 
por: Turner, Anne-Marie W., et al.
Publicado: (2017)

Experimental Systems for Measuring HIV Latency and Reactivation
por: Fujinaga, Koh, et al.
Publicado: (2020)

HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication
por: Andre, Mickensone, et al.
Publicado: (2023)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
por: Khanal, Sushant, et al.
Publicado: (2021)

Bioinformatics and HIV Latency
por: Ciuffi, Angela, et al.
Publicado: (2015)

HIV-1 latency in activated T-cells
por: Berkhout, Ben
Publicado: (2013)

Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer?
por: Singh, Meera V., et al.
Publicado: (2017)

Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency
por: Schiralli Lester, Gillian M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lv5dk3e24ks9gd2qn27j1eihes